Dean Popovski
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy.
Journal: Neuro-oncology advances
Published: January 30, 2025
Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward.
Journal: Neuro-oncology
Published: September 15, 2023
Targeting MEK/MELK in atypical teratoid rhabdoid tumor: a treatment approach aimed at exploiting blood-brain barrier deficiencies.
Journal: Neuro-oncology
Published: November 12, 2019
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor.
Journal: Cancer cell
Published: February 11, 2019
The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53.
Journal: Oncogene
Published: June 19, 2017
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 30, 2015
The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
Journal: BMC cancer
Published: September 16, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026